Sarcopenia index (serum creatinine/cystatin C ratio) independently identifies sarcopenia risk and mortality in older hospitalized patients with type 2 diabetes mellitus: a retrospective analysis
Sarcopenia is increasingly recognized as a complication of type 2 diabetes mellitus (T2DM); however, simple screening tools for hospitalized older adults remain limited. The sarcopenia index (SI), calculated as serum creatinine (mg/dL)/cystatin C (mg/L) × 100, has been proposed as a readily available biomarker of muscl...